Though researchers are still learning about their long-term effects, GLP-1s have surged in popularity, even as established interventions that have nothing to do with body size, like vitamin K shots for infants and life-saving vaccines, are increasingly rejected
Guidelines for use in obesity Semaglutide is recommended as an option for weight management, including weight loss and weight maintenance, alongside a reduced-calorie diet and increased physical activity in adults, only if: it is used for a maximum of 2 years, and within a specialist weight management service providing multidisciplinary management of overweight or obesity (including but not limited to tiers 3 and 4), and they have at least 1 weight-related comorbidity and : a body mass index (BMI) of at least 35.0 kg/m2, or a BMI of 30.0 kg/m2 to 34.9 kg/m2 and meet the criteria for referral to specialist weight management services in NICEs guideline on obesity: identification, assessment and management
It is unclear if semaglutide causes the same effect in humans
UK guidance typically recommends a more gradual weight loss of 0.5-1 kg per week where feasible
Benefits of lifestyle-aligned timing include: Improved appetite control on weekends Better portion control Reduced binge eating Greater consistency with a healthy diet Improved confidence and adherence This approach supports long-term weight loss , not short-term restriction